 |
 |

Effect of β-Adrenergic Blockade on the Growth Rate of Abdominal Aortic Aneurysms
Steven D. Leach, MD;
Allan L. Toole, MD;
Harold Stern, MD;
Ralph W. DeNatale, MD;
M. David Tilson, MD
Arch Surg. 1988;123(5):606-609.
Abstract
 |  |
We retrospectively identified 136 patients with abdominal aortic aneurysms (AAAs) who were initially evaluated as outpatients. Twenty-seven of these patients met the following criteria for eligibility in the study: (1) roentgenographic documentation of an AAA larger than 3 cm, (2) at least two serial ultrasound size determinations over a minimum six-month interval, and (3) a documented medication history. Of these 27 patients, 12 received long-term β-blockade, while 15 received no β-blockade. The two groups were comparable with respect to age, sex, initial aneurysm size, mean systolic and diastolic blood pressure, and duration of follow-up (mean, 34 months). Among patients with β-blockade, the mean growth rate was 0.17 cm/y. The rate for the controls was 0.44 cm/y. One patient of 12 (8%) in the β-blocker group had a rate that exceeded the mean for the overall group compared with eight patients of 15 (53%) in the group with no β-blockade. This difference was statistically significant. Thus, β-blockade may be associated with a decreased AAA growth rate in this small, retrospective study.
(Arch Surg 1988;123:606-609)
Author Affiliations
From the Department of Surgery, Yale University School of Medicine, New Haven, Conn.
Footnotes
Accepted for publication Jan 29, 1988.
Read before the Annual Meeting of the New England Surgical Society, Bretton Woods, NH, Sept 19, 1987.
Reprint requests to Department of Surgery, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06510 (Dr Tilson).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Medical Management of Small Abdominal Aortic Aneurysms
Baxter et al.
Circulation 2008;117:1883-1889.
ABSTRACT
| FULL TEXT
Detection, Management, and Prospects for the Medical Treatment of Small Abdominal Aortic Aneurysms
Powell and Brady
Arterioscler. Thromb. Vasc. Bio. 2004;24:241-245.
ABSTRACT
| FULL TEXT
Prospects for the Medical Management of Abdominal Aortic Aneurysms
Steinmetz et al.
VASC ENDOVASCULAR SURG 2003;37:151-163.
ABSTRACT
Intramural Hematoma of the Aorta: Predictors of Progression to Dissection and Rupture
von Kodolitsch et al.
Circulation 2003;107:1158-1163.
ABSTRACT
| FULL TEXT
Chronic {beta}-blocker therapy improves outcome and reduces treatment costs in chronic type B aortic dissection
Genoni et al.
Eur. J. Cardiothorac. Surg. 2001;19:606-610.
ABSTRACT
| FULL TEXT
Circadian Variation in the Rupture of Abdominal Aortic Aneurysms
Meissner et al.
VASC ENDOVASCULAR SURG 1998;32:577-586.
ABSTRACT
Determining Surgical Indications for Acute Type B Dissection Based on Enlargement of Aortic Diameter During the Chronic Phase
Kato et al.
Circulation 1995;92:107-112.
ABSTRACT
| FULL TEXT
Progression of Aortic Dilatation and the Benefit of Long-Term {beta}-Adrenergic Blockade in Marfan's Syndrome
Shores et al.
NEJM 1994;330:1335-1341.
ABSTRACT
| FULL TEXT
Utility of Computed Tomography for Surveillance of Small Abdominal Aortic Aneurysms: Preliminary Report
Krupski et al.
Arch Surg 1990;125:1345-1350.
ABSTRACT
Effect of {beta}-Adrenergic Blockade on the Growth Rate of Abdominal Aortic Aneurysms
DALESSANDRI
Arch Surg 1989;124:388-389.
ABSTRACT
|